Skip to content
10-Q

Quarterly Report

INNOVUS PHARMACEUTICALS, INC.

0001437749-19-010044

← back to feed
Filed
May 15, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2019 · May 13, 2019 2.62M sh
Operating Cash Flow Q1 2019 · Mar 31, 2019 −$602K
Operating Cash Flow restated Q1 2019 · Mar 31, 2018 −$663K
Short Term Debt Q1 2019 · Mar 31, 2019 $2.23M
Short Term Debt Q1 2019 · Dec 31, 2018 $3.07M
Stockholders Equity Q1 2019 · Mar 31, 2019 $1.06M
Stockholders Equity Q1 2019 · Dec 31, 2018 $109K
Stockholders Equity restated Q1 2019 · Mar 31, 2018 $2.71M
Stockholders Equity restated Q1 2019 · Dec 31, 2017 $903K
Current Liabilities Q1 2019 · Mar 31, 2019 $7.25M
Current Liabilities Q1 2019 · Dec 31, 2018 $7.35M
Total Liabilities Q1 2019 · Mar 31, 2019 $10.31M
Total Liabilities Q1 2019 · Dec 31, 2018 $10.02M
Current Assets Q1 2019 · Mar 31, 2019 $5.78M
Current Assets Q1 2019 · Dec 31, 2018 $5.02M
Total Assets Q1 2019 · Mar 31, 2019 $11.37M
Total Assets Q1 2019 · Dec 31, 2018 $10.13M
Sga Expense Q1 2019 · Mar 31, 2019 $2.44M
Sga Expense restated Q1 2019 · Mar 31, 2018 $1.7M
Rd Expense Q1 2019 · Mar 31, 2019 $56K
Rd Expense restated Q1 2019 · Mar 31, 2018 $11K
Net Income Q1 2019 · Mar 31, 2019 −$1.99M
Net Income restated Q1 2019 · Mar 31, 2018 −$1.83M
Operating Income Q1 2019 · Mar 31, 2019 −$1.5M
Operating Income restated Q1 2019 · Mar 31, 2018 −$1.33M
Gross Profit Q1 2019 · Mar 31, 2019 $3.59M
Gross Profit Q1 2019 · Mar 31, 2018 $3.68M
Cost Of Revenue Q1 2019 · Mar 31, 2019 $1.78M
Cost Of Revenue Q1 2019 · Mar 31, 2018 $864K
Revenue Q1 2019 · Mar 31, 2019 $5.36M
Revenue Q1 2019 · Mar 31, 2018 $4.55M
Capex restated Q1 2019 · Mar 31, 2018 $148K